Vikram Malik's Net Worth
$122 Million
Who is Vikram Malik?
Vikram Malik has an estimated net worth of $122 Million. This is based on reported shares across multiple companies, which include Evolus, Inc., and AEON Biopharma, Inc..
SEC CIK
Vikram Malik's CIK is 0001730123
Past Insider Trading and Trends
2023 was Vikram Malik's most active year for acquiring shares with 13 total transactions. Vikram Malik's most active month to acquire stocks was the month of June. 2021 was Vikram Malik's most active year for disposing of shares, totalling 5 transactions. Vikram Malik's most active month to dispose stocks was the month of July. 2019 saw Vikram Malik paying a total of $24,999,994.25 for 1,313,201 shares, this is the most they've acquired in one year. In 2021 Vikram Malik cashed out on 155,000 shares for a total of $1,626,153.74, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Evolus, Inc. (EOLS) Snapshot price: $13.15
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.95% | -7.50K |
$12.96 | -$97,203.00 | 246.51K |
Jun 3
| |||
Form 4
| -9.93% | -28.00K |
$12.93 | -$362,012.00 | 254.01K |
May 13
| |||
Form 4
| +2.35% | 6.46K |
—
|
—
| 282.01K |
Feb 7
| |||
Form 4
| +255.16% | 197.97K |
$7.41 | $1,296,505.47 | 275.55K |
Aug 11 - Aug 15
| |||
Form 4
| +11.97% | 8.29K |
—
|
—
| 77.58K |
Jan 27
| |||
Form 4
| +28.98% | 15.57K |
—
|
—
| 69.29K |
Jan 24
| |||
Form 4
| -2.23% | -26.08K |
$11.00 | -$286,721.83 | 1.14M |
Aug 23
| |||
Form 4
| -5.02% | -61.84K |
$10.59 | -$654,870.86 | 1.17M |
Aug 19 - Aug 20
| |||
Form 4
| -5.17% | -67.08K |
$10.20 | -$684,561.06 | 1.23M |
Aug 17 - Aug 18
| |||
Form 4
| +50.43% | 18.01K |
—
|
—
| 53.72K |
Mar 26
| |||
Form 4
| +117.76% | 19.31K |
—
|
—
| 35.71K |
Feb 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
∞
| 1.3M |
$19.25 | $24,999,994.25 | 1.3M |
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
| +90.70% | 7.8K |
$13.04 | $101,688.60 | 16.4K |
Dec 17
| |||
Form 4
|
∞
| 8.6K |
$28.88 | $248,353.38 | 8.6K |
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AEON Biopharma, Inc. (AEON) Snapshot price: $9.21
President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +101.29% | 6.99M |
—
|
—
| 13.89M |
Jul 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |